NEUREN PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.34 AUD | +5.64% |
|
+6.17% | -14.54% |
| 05-09 | Neuren Pharmaceuticals Partner Acadia Pharmaceuticals Posts US DAYBUE Sales of $75.9 Million | MT |
| 04-24 | Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 21.51 | 25.11 | 24.97 |
| Spread/Res. | -0.79% | -15.01% | -14.54% |
| Spread/Supp. | +14.42% | +50.49% | +34.72% |
| Support | 18.65 | 14.18 | 15.84 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- NEU Stock
- Charts Neuren Pharmaceuticals Limited
